Abstract Mood disorders and health risk behaviors increase in adolescence. Puberty is considered to contribute to these events. However, the precise impact of pubertal hormone changes to the emergence of mood disorders and risk behaviors is relatively unclear. It is important that inappropriate attribution is not made. Our aim was to determine what is known about the effect of endogenous estradiol on human adolescent girls' mood and behavior. The databases searched were MEDLINE, Embase, PsycINFO, Education Resources Information Center (ERIC), Pre-MEDLINE, Web of Science, and Scopus for all dates to October 2014. For inclusion, contemporaneous hormone and mood or behavioral assessment was required. Data were extracted following a template created by the authors. Fourteen studies met our inclusion criteria. There was some consistency in findings for mood and estradiol levels, with associations between estradiol and depression and emotional tone and risk taking. Results were less consistent for studies assessing other mood and behavioral outcomes. Most studies were cross-sectional in design; assay methodologies used in older studies may lack the precision to detect early pubertal hormone levels.
Introduction
Adolescence is a formative time for an individual's identity, development, and functioning [12] . During this time, longterm behavioral and affective patterns, as well as psychopathologies, emerge [14] . Puberty is the universal biological event of adolescence, and the primary purpose of which is to achieve adult reproductive capacity [11, 32] . Puberty involves dramatic and well-remembered physical changes [40] , and it is perhaps unsurprising that, intuitively, these changes are allocated as important in both physical and psychosocial contexts.
The popular assertions of adolescence as a time of "puberty blues," "storm and stress," or other behavioral changes [6, 8] are palpably not correct [5] for all adolescents. Certain problem behaviors and mental health issues do emerge during adolescence [12, 25] , and deterioration in health may be linked to such behavioral changes [47] . These include the appearance of sex differences in the prevalence of depression (the prevalence of depression in females is twice that of males) [27] , increased sensation seeking [14, 38] , substance use [22] , and disordered eating [30] . For girls, depressive illnesses, selfimage, and eating disorders are of particular concern. Gender differences and the coincidental increase in pubertal hormones at this time of increased risk implicate some role for sex hormones. However, there exists no systematic analysis of the literature.
Given the importance of non-biological factors such as social, family, and peer relations in the development of adolescent behaviors and affect [46] , it could be postulated that hormones influence adolescent behavior indirectly, either by modulating internal status reactivity to modify affect or by the effect on others of phenotypic development [6] . While the hormone levels remain high after puberty, behavioral and mood disorders often ameliorate, giving rise to popular notions of puberty blues being confined to this period alone. Whether some of these mood and behavioral changes fail to abate in certain individuals is unclear. It is important to understand the true effect and duration of that effect of sex hormones on adolescent mood and behavior, so that clinicians can target established, evidence-based interventions to those most at risk [40] . Additionally, while diagnosable psychiatric conditions increase in prevalence, many parents will describe mood and behavioral changes despite of the absence of an identifiable mental illness. While these changes fall within a normal spectrum of mood or behavior, these can still be confronting and challenging to the parent and adolescent alike.
The age of onset of puberty in many Western countries has declined over the recent decades [1, 11] , with earlier exposure to rising levels of estradiol, the primary puberty hormone in females. This is an additional reason to better understand how estradiol affects the mood and behavior in the pubertal transition and which girls might be especially at risk for any negative impacts of their puberty hormones.
One specific mechanism for any effect of estradiol might be through central neural monoamine systems, which have been implicated in a wide range of mood and behavioral disorders [9, 31] . Estradiol may also induce the formation of new synapses [36] . Such a neuroarchitectural effect is part of the organizational and activational effects hypothesis, wherein steroi ds act during brain development to alter neuroarchitecture, which limits the repertoire of the brain's responses when acted upon by that hormone later in life (activation) [9, 24] . An example of such activation is the commencement of reproductive behavior in adulthood, which is programmed earlier during the organization phase of neural development [24] .
Animal studies, especially those in rodents [17, 29] , have informed the role of estradiol in adolescent behavior. For example, the importance of estradiol in sexually differentiated behavioral patterns in rodents [3] and other animals [21] may provide hypotheses as to sex-based behavioral differences in humans. While these studies proffer putative roles for estradiol in human mood and behavior, we know that the variation between different animal species is significant [4] and it is difficult to adequately model the complexities of human behavior and mood in animal settings.
The aim of this systematic review was to determine what evidence exists for the true effect of the endogenous puberty hormone, estradiol, on adolescent girls' mood and behavior.
Methods

Search strategy
A systematic search was conducted to identify publications on the effect of endogenous estradiol on mood and behavior in healthy adolescent girls (10-19 years) using the terms as laid out in Appendix A. The following databases were searched: MEDLINE, Embase, PsycINFO, Education Resources Information Center (ERIC), Pre-MEDLINE, Web of Science, and Scopus from the date of database inception to October 2014. No language limits were set. The search strategy for MEDLINE is included in Appendix A, with search terms for the other databases modified to their requirements. Where relevant, reference lists were hand searched for further records. No initial restrictions were placed upon publication type.
Inclusion criteria
To be considered for this review, study participants were female adolescents (10-19 years) from community samples, with no specified diseases. Institutionalized or incarcerated populations were excluded, unless a control group was reported separately, due to potential confounders for behavioral outcomes. Study participants must have undergone or be undergoing spontaneous puberty. Thus, studies involving exogenous estradiol or other estrogens were excluded. The use of oral contraceptive pill was also a criterion for exclusion, as these preparations contain synthetic and biologically potent estrogens that suppress endogenous estradiol production. In the event that a study did not explicitly define oral contraceptive use, authors were contacted for further information.
Estradiol measurement in blood, saliva, or urine was required, with the laboratory methodology provided. Though assay methodology and quality has improved markedly over the past decades, we did not limit studies by assay type. It should be noted that, even now, assays might not be able to detect very low (i.e., prepubertal and early pubertal) estradiol levels with adequate sensitivity [35] . We considered whether to include only studies that used a standardized time of biological data collection, in order to control for known diurnal physiological variation in estradiol in early puberty [11] . If we had adhered to this criterion, the only study to be excluded would have been a large, longitudinal study in which the collection time for the majority of samples was relatively constant [2] . Only one study performed in females controlled for cycle time [23] . In the others, there was no stratification for pre-or postmenarchal status and, hence, there was no explicit control for menstrual cycle. We decided not only to retain these (all cross-sectional) studies but also to address the inherent limitations of this approach in the discussion. Studies were included if mood and/or behavioral outcomes were measured using a recognized, validated tool and with the mood/behavioral measurement concurrent with hormone measurements.
Studies on the effects of estradiol generally do not account for the potential confounding effects of testosterone, and thus, testosterone was not addressed in the review. The mood or behavioral effects of progesterone were considered beyond the scope of the review, as we were interested in the pubertal transition rather than in the mature adult ovulatory cycle where progesterone-induced mood variation is possible [34] .
Specific moods and behaviors sought included depression, anxiety, eating disorders, and self-image disturbance; social interactions; aggressive, disruptive, or conduct-disordered behavior; and risk taking including substance abuse. Studies were excluded if these addressed primarily sexual behaviors as such behaviors are essential for reproduction which is the key biological function of puberty [11] .
Data collection and analysis
Selection of studies
Once irrelevant studies and duplicates were removed, one reviewer (BB) scanned the title, abstract, and keywords of the remaining articles. Where a reference seemed suitable for the review, the full text was retrieved for further analysis by two reviewers (BB and KS) and was either included or excluded based on the above criteria.
Data extraction
Information was extracted from each study into a template developed by the authors. The following information was recorded: participants (sample size, sex, and age range), affect or behavior measured (type, measurement tool, and its validity), estradiol measurement (assay type, time of day, and time of cycle where available), assessment of pubertal status (method used, examination, self-report, or parental report), study outcomes, and discussion of limitations. These data are described in Tables 1 and 2 .
Quality assessment
A general methodology for quality assessment was followed, based on checklists for the evaluation of studies [16, 48] , and is reported in Table 3 and in the Results section.
Statistical analyses
Given the heterogeneity of the outcomes and outcome measures in this systematic review, no further analyses (such as meta-analysis) could be performed and the results are presented as descriptive data.
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [26] was followed in the writing of this review.
Results
Search results
The result of the searches is displayed in Fig. 1 . Of the initial 9904 results obtained from database searches, 9574 were removed. Three additional studies were identified from manual reference list searching. After exclusion based on abstracts, the remaining 76 citations were inspected in full text. Fourteen of these met the inclusion criteria. The reviewers had full consensus in their findings. All included publications were written in English.
The 62 full-text articles which were excluded, as well as the reasons for their exclusion, are detailed in Appendix B. Participant age, lack of estradiol measurement, and oral contraceptive use were the main reasons for exclusion.
Included studies
Fourteen studies met the inclusion criteria. These studies are summarized in Tables 1 and 2 . Thirteen studies used a standard radioimmunoassay measurement of estradiol for blood samples. One used an enzyme-linked immunoassay in saliva [20] . Three studies [2, 37, 41] were longitudinal, and the remainder was cross-sectional, whether by study design or analysis. Four of the studies were based on the same participant sample [28, 41, 43, 44] . Nine of 14 studies examined mood and affect alone, and 11 out of 14 studies examined aggression, delinquency, and behavioral or conduct disorders. Six of the nine studies on aggression also included an assessment of mood and affect.
For clarity of interpretation, the variables of interest were grouped under four categories: mood and affect (A); selfimage and social competency and related behaviors (B); risk taking, sensation seeking, and substance use (C); and D: aggression, behavior/conduct disorder, and delinquency (D) as shown in Table 1 . The groupings describe similar outcomes so that a degree of inter-study comparison can be made in the absence of formal meta-analysis. Most of the included studies considered more than one categorical outcome, and in order to reduce repetition, we have not looked at the four outcome categories separately. In addition, most studies were unable to demonstrate an association, so repetition of negative findings is also reduced. As previously stated, it was not possible, due to heterogeneous outcomes, to perform a meta-analysis.
Study data
The studies characterized in Table 1 are further detailed in  Table 2 . The most important findings are briefly summarized below.
Mood and affect (category A)
Most of the studies considered mood and affect. The studies can be summarized as follows: female sample size varied from Differential association refers to the theory that a risk-taking behavior is learned through interactions with risk-taking peers [45, 46] 52 to 339, with a mean of 122 and median 100. The age ranges of these subjects are listed in Table 1 . In the nine publications considering this domain, 13 different measures were used for participant assessment. All of these studies were based on the community samples from the USA. Mood was investigated in different ways, such as Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) depression [2] , emotional tone (variability in mood) [15, 37, 41, 44] , depressive affect [7, 47] , and anxiety [33] . While these studies do not all examine the same aspects of mood or affect, all do consider what can be identified as pathological or maladaptive states. Susman's longitudinal study in 52 girls over 1 year considered the roles played by several hormones (luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol dehydroepiandrosterone and its sulfate, androstenedione, and cortisol) in a variety of negative affective states: emotional tone, internalizing behavior problems, and symptoms of depression and anxiety. Longitudinal data were given for emotional tone and internalizing behavior problems, though only cross-sectional data were provided for depression and anxiety symptoms. For girls, no significant cross-sectional relationships were observed between estradiol and any of the study outcomes, though longitudinal analyses showed a significant positive relationship between estradiol and increased emotional tone [41] . Slap et al. [37] found no longitudinal association between estradiol and mood. This study followed girls for 1 year, focusing on changes in self-image throughout puberty. Emotional tone was one scale of interest for their questionnaire. Regression analyses did not find a relationship between changes in estradiol and changes in emotional tone over 1 year. It should be noted that there was a significant decline in emotional tone scoring (indicating a more variable mood), though changes in estradiol were not significant between baseline and follow-up. In contrast, Angold's larger (n=339) 3-year longitudinal study found an approximately linear relationship between estradiol and depression, which was diagnosed by interview using DSM-IV criteria [2] . This study found that the odds ratio of estradiol changes being related to depression was significant (odds ratio 2.5, 95 % confidence interval 1.5 to 4.3). Additionally, Angold's study found that estradiol was more strongly related to depression than Tanner stage, supporting, not unexpectedly, the primacy of hormone change over morphological change in providing an etiological basis for depression in their cohort. When estradiol levels were divided into quintiles, the percentage of girls with DSM-IV depression was approximately linear as hormone levels increased.
Two cross-sectional studies observed that estradiol had a nonlinear relationship with depressive affect. When estradiol concentration was reported as quartiles, depression was lowest in the pre-and postpubertal quarters (bottom 25 % and uppermost 25 %, respectively) and highest in the transition between these two [7, 47] . For Brooks-Gunn's data, there were significant interactions between negative life events and hormonal levels in depression rating [7] . In Rapkin's study, anxiety was inversely correlated with estradiol when hormone levels were tertiled. Without categorization, estradiol was not significantly correlated with anxiety; however, the authors note a trend to this correlation (p=0.051) between the two variables. Of the seven cross-sectional analyses, emotional tone was considered in three [15, 41, 44 ]. Susman's results from 1991 are reported above, as both longitudinal and cross-sectional analyses were provided. An earlier paper in the same data set did not find any significant cross-sectional relationship with emotional tone and estradiol [44] . Both of these studies used different mood assessment tools. In contrast to Susman's studies, more recent work in a larger study population (n=100) observed a correlation between estradiol and emotional tone [15] .
Self-image, social competency, and related behaviors (category B)
Slap et al. [37] found no longitudinal association between changes in estradiol and self-image. In contrast, crosssectional studies observed correlations between estradiol and body-esteem [10] and with the appearance of genetically influenced eating disorder attitudes and behaviors [19] . In the study of Davison et al. [10] , a negative correlation between estradiol and body-esteem was observed at 11 years in girls, though not at any other time points. Nottelmann et al. [28] found no association between estradiol and body image.
Risk taking, sensation seeking, and substance use (category C) A significant correlation was found between the level of estradiol and alcohol use in the study of Martin et al. [23] . No relationship between estradiol and other substance use was identified. In a large Belgian population-based study, Vermeersch et al. [45] found positive relationships between total and free estradiol in girls and risk taking. Aggressive risk taking was most evident at mid-cycle (defined by the investigators as an estradiol of greater than 60 pg/mL (220 pmol/L) [23] ), with non-aggressive risk taking showing no such cycle effect. Records after obviously irrelevant, duplicates and reviews removed (n = 330)
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category D)
There were limited data in this category. Brooks-Gunn and Warren [7] and Nottelmann et al. [28] both observed no correlation between estradiol and aggression in their studies [7, 28] . Graber et al. [15] found that aggression only correlated with estradiol in females when negative life events were included as a mediating effect.
Quality assessment Table 3 provides a detailed description of quality assessment.
No study included a power analysis, nor were there adequate descriptions of sampling methods. Four studies specified exclusion criteria. Of the 14 studies, only Martin et al. [23] controlled for menstrual cycle. Though Angold's study did not use exact timing of sample collection, approximately three quarters of samples were collected at consistent times which the authors report as minimizing a diurnal variation effect [2] . With respect to confounding factors, four studies accounted or controlled for factors such as age and socioeconomic status.
Discussion
This systematic review is the first to examine the effect of estradiol levels on mood and behavior in adolescent girls. It is timely because long-standing assumptions and the evidence regarding sex hormone effects on adolescent mood and behavior have never been comprehensively explored. With the growing awareness of mood and behavioral changes in adolescents, confirming or challenging these assumptions is important to develop or refine new paradigms in the diagnosis and management. Given the earlier onset of female puberty [1, 11] it is important to be aware of when any estradiol effects might be expected to occur, especially as there are established links between early and late onset of female mood and behavioral problems [18, 28, 30, 39] . The review demonstrated reasonably consistent findings on mood and affect, with depression and increased mood variability being positively correlated with estradiol for at least some stages of puberty. Associations were most consistently observed between estradiol concentrations and depressive states during the transition from prepubertal to adult estradiol levels [2, 7, 15, 47] , suggesting that tempo or rapidity of hormone change might play a part. A positive correlation was generally observed between estradiol and affective variability [15, 41, 44] . While mood variability more likely reflects puberty blues than does DSM-IV diagnosed depression [2] , both benign and pathological changes in mood and affect are important causes of parental and adolescent concern during puberty. We have shown that both of these have some association with estradiol levels. There was no clear consistency of estradiol effect for behaviors such as aggression, behavior/conduct disorder, and delinquency (see "Aggression, behavior/conduct disorder, and delinquency (category D)"). These behaviors are more often (falsely) associated with testosterone, as another review by our group has shown [13] .
The cross-sectional nature of all but three studies limits the conclusions of this review. Thus, reported outcomes can only show associations between estradiol concentrations and the affect or behavior of interest. Causality cannot be inferred, as an association could be a persistent relationship, short-term change, or mere coincidence [42] ; likewise, the direction of the effect can only be postulated. Additionally, four of the studies were from the same cohort [28, 41, 43, 44 ] and three of these described similar outcomes (all assessed with different scales), which risks the overrepresentation of their data. Only four of the 12 cross-sectional studies controlled for potential confounders such as socioeconomic status.
Brooks-Gunn et al., in their study, estimated that only 1 % of variance in negative emotional expression was due to estradiol [7] . Environmental and social factors or determinants in an individual may mediate or amplify susceptibility to behavioral or affective changes as a result of pubertal hormone change [42] . Angold et al. postulated that hormonal influences on mood and behavior are less causative than sensitizing; that is, pubertal increases in sex hormones surpass a threshold that would render one more likely to alter affect or behavior [2] . That one fifth of samples had hormone levels that fell below the assay limits of detection, and the timing of sample collection was not as rigorous as the other studies should be viewed to have specific study limitations.
The studies appraised in this systematic review are both observational and primarily cross-sectional. Longitudinal cohort studies would provide the best evidence for an effect, if any, of estradiol on adolescent mood and behavior, and this was the finding in the large longitudinal study by Angold et al. [2] .
None of the studies in the systematic review addressed mechanisms for a putative relationship between estradiol and behavior and/or mood. Such mechanisms are likely primarily central. Estrogens, especially estradiol, have been shown to modulate genetic expression in neural monoamine systems (such as the dopaminergic, serotonergic, and noradrenergic systems) [9, 31] . These systems are commonly targeted by psychotropic drugs such as monoamine oxidase inhibitors and selective serotonin reuptake inhibitors, which support at least a role for estradiol in the onset or progression of mood or behavioral disorders. Pubertal hormone changes are often thought to modulate mood and behavior by activating previously organized neuroarchitecture (see "Introduction"). It would be anticipated that these changes persist into adulthood, but given the limited follow-up in the studies reviewed, we cannot postulate as to whether the effects of estradiol in this regard are persistent. Regardless, it is important to consider how sex hormone changes might affect adolescent mood and behavior, especially given the salient increase in psychopathology during and after adolescence and the importance of earlier intervention.
This systematic review has several strengths. Our methodology included comprehensive searches of many databases of potential relevance to this review as well as detailed data extraction and quality analysis. Of the 14 included studies, seven included more than 100 girls.
There are a number of limitations. The studies included in the systematic review used a range of measurement tools to assess behavior and affect, and a meta-analysis or a quantitative analysis of the collected study data was not possible. There may be a bias in that only published manuscripts were included in our final analysis, but as a counter to this argument, published studies had mainly negative findings. Information about the quality of the environment and early life stresses experienced by the participants was not offered in the majority of the studies. These factors might well contribute to any aberrant moods or behaviors and, thus, are important confounders.
The irregular nature of menstrual cycles for some time after menarche makes the control for menstrual cycle difficult in any study and was only done in one of the retained studies. Failing to control for menstrual cycle may be a limitation of the review. Alternatively selecting a specific phase of the cycle (follicular, mid, or luteal) may also skew the findings: if samples were not collected in the mid-follicular phase, progesterone may be a confounding factor. The most important methodological limitation of every study is the method of estradiol measurement. The American Endocrine Society consensus statement on estradiol measurement [35] concludes that even current assays are inadequate for prepubertal estradiol measurement, indicating that the methodologies of the reviewed studies may lack sufficient sensitivity to detect estradiol, especially at low levels, or indeed to measure with enough specificity mid-puberty levels. In older, less sensitive assays, especially estradiol-mediated effects will be underestimated if too many estradiol levels are below the limits of quantification.
In conclusion, this systematic review has found that there are insufficient longitudinal data of high methodological quality to confirm that the rise in estradiol during puberty plays a causative role in adolescent mood and behavioral changes, though the current evidence clearly suggests that such a relationship exists. Future studies would require sufficient duration and frequency of sampling of biological markers, adequate statistical power, and the use of mass spectrometry techniques to clarify the role of estradiol. However, given the intra-and interindividual variability of estradiol levels from the beginning of puberty onwards and the variation in timing and tempo of puberty, it is possible that even with careful longitudinal studies, the assignation of a causal role may prove to be elusive.
We believe that it is important for health professionals to take care when attributing adolescent psychopathology to puberty hormones, as the current data supporting these assertions are limited. Both timing and tempo of puberty may contribute to vulnerability in certain adolescents, particularly if other adverse psychosocial circumstances exist. Such adolescents may require a supportive intervention during their adolescence in order to ensure that health trajectories are optimized. To this end, further understanding on how the dramatic rise in estradiol during puberty affects the adolescent girls' mood and behavior has important public health repercussions.
